Suchergebnisse - "Rice, Todd W"

PubPharm (25)

1

Protection of Messenger RNA Vaccines Against Hospitalized Coronavirus Disease 2019 in Adults Over the First Year Following Authorization in the United States

enthalten in: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America | 2023

von Tenforde, M. | Self, W. | Zhu, Y. | +58

2

Comparison of test-negative and syndrome-negative controls in SARS-CoV-2 vaccine effectiveness evaluations for preventing COVID-19 hospitalizations in the United States

enthalten in: Vaccine | 2022

von Turbyfill, C. | Adams, K. | Tenforde, M. | +51

3

Effectiveness of the Ad26.COV2.S (Johnson & Johnson) Coronavirus Disease 2019 (COVID-19) Vaccine for Preventing COVID-19 Hospitalizations and Progression to High Disease Severity in the United States

enthalten in: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America | 2022

von Lewis, N. | Self, W. | Gaglani, M. | +54

4

mRNA Vaccine Effectiveness Against Coronavirus Disease 2019 Hospitalization Among Solid Organ Transplant Recipients

enthalten in: The Journal of infectious diseases | 2022

von Kwon, J. | Tenforde, M. | Gaglani, M. | +52

5

Use of pragmatic and explanatory trial designs in acute care research : lessons from COVID-19

enthalten in: The Lancet. Respiratory medicine | 2022

von Casey, J. | Beskow, L. | Brown, J. | +16

CommentIn: Lancet Respir Med. 2022 Jul;10(7):625-627. - PMID 35709826

6

Associations between persistent symptoms after mild COVID-19 and long-term health status, quality of life, and psychological distress

enthalten in: Influenza and other respiratory viruses | 2022

von Han, J. | Womack, K. | Tenforde, M. | +20

7

Low-risk penicillin allergy delabeling through a direct oral challenge in immunocompromised and/or multiple drug allergy labeled patients in a critical care setting

enthalten in: The journal of allergy and clinical immunology. In practice | 2022

von Koo, G. | Stollings, J. | Lindsell, C. | +8

8

Effectiveness of mRNA Vaccines Against COVID-19 Hospitalization by Age and Chronic Medical Conditions Burden Among Immunocompetent US Adults, March-August 2021

enthalten in: The Journal of infectious diseases | 2022

von Lewis, N. | Naioti, E. | Self, W. | +155

9

Effectiveness of Severe Acute Respiratory Syndrome Coronavirus 2 Messenger RNA Vaccines for Preventing Coronavirus Disease 2019 Hospitalizations in the United States

enthalten in: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America | 2022

von Tenforde, M. | Patel, M. | Ginde, A. | +56

UpdateOf: medRxiv. 2021 Jul 08;:. - PMID 34268515

10

Clinical severity of, and effectiveness of mRNA vaccines against, covid-19 from omicron, delta, and alpha SARS-CoV-2 variants in the United States : prospective observational study

enthalten in: BMJ (Clinical research ed.) | 2022

von Lauring, A. | Tenforde, M. | Chappell, J. | +57

UpdateOf: medRxiv. 2022 Feb 07;:. - PMID 35169811